Validation of the Quantum Physics Processes Underlying the Integrated Optimization of Proton FLASH Radiotherapy
Abstract
FLASH is a new treatment modality that requires optimization of dose, dose rate, and LET. Here we validate these three quantities under FLASH conditions, which includes the quantum uncertainty in the time-dependent instantaneous dose rate (IDR) curves and LET spectra that underlie the newly proposed integrated optimization framework. Measurements of dose, IDR, and LET were performed at the Emory Proton Therapy Center using a FLASH proton beam with a nominal energy of 250 MeV and a 3D printed ridge filter. Because 3D printing resin is made from a proprietary chemical formula, we developed a method for realistically characterizing and modeling the material in simulations. Absolute dose in 3D space was measured using a 2D MatriXX PT detector as well as by a novel 4D multi-layer strip ionization chamber (MLSIC), which also simultaneously measures IDR. Further timing data was measured in the secondary beam by detecting prompt gammas using a Minipix Timepix3; a second detector, Advapix Timepix3, was used to measure LET. To account for the quantum mechanical nature of particle transport, we developed a technique for detecting individual protons within a high flux primary beam, which was necessary for properly measuring LET spectra. TOPAS simulations agreed with measurement, with absolute dose typically having a gamma passing rate of at least 95% (3 mm/3% criteria). Likewise, IDR and LET showed good agreement, with averaged IDR values agreeing within 0.3% with fluctuations on the…
Read the paper
Related studies
- Quantum dots: synthesis, bioapplications, and toxicity
- A Guide to In Silico Drug Design
- Quantum Computing for Healthcare: A Review
- Automated in Silico Design of Homogeneous Catalysts
- Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach
- In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.